April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Peripheral Exudative Hemorrhagic Chorioretinopathy
Author Affiliations & Notes
  • Guido R. Kuerzinger
    Eye Hospital, University Ulm, Ulm, Germany
  • Gabriele E. Lang
    Eye Hospital, University Ulm, Ulm, Germany
  • Footnotes
    Commercial Relationships  Guido R. Kuerzinger, None; Gabriele E. Lang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5009. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Guido R. Kuerzinger, Gabriele E. Lang; Peripheral Exudative Hemorrhagic Chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5009.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is an age-related retinal degeneration with choroidal neovascularization (CNV). PEHCR has much less attention in the ophthalmic literature as the age-related macular degeneration (ARMD). It is unclear whether the lack of articles about PEHCR is due to the often asymptomatic nature of the disease or the low incidence. PEHCR can also be sight-threatening and rarely lead to blindness.

Methods: : Twelve patients (13 eyes) with PEHCR were examined between January 2008 and October 2010. The protocol included referral diagnosis, best corrected visual acuity before and after treatment (BCVA), age, sex, ophthalmoscopy, fundus photography, optical coherence tomography (OCT), fluorescein angiography (FAG), ultrasound findings and disease of the fellow eye. Data were analyzed descriptively.

Results: : Most common referral diagnosis of patients with PEHCR was retinal detachment. Patient age ranged from 76 to 89 years (median: 85 years). The sex distribution was female:male, 8:4. BCVA before treatment was 0.1 to 0.8 (median: 0.5), post-treatment 0.05 to 1.0 (median: 0.5). The ultrasound findings revealed a length between 4.73 mm and 10.23 mm (median: 8.0 mm), a latitude between 4.9 mm and 9.13 mm (median: 6.50 mm) and a prominence between 1.74 mm and 4.0 mm (median: 2.42 mm). 7/13 lesions were localized in the outer periphery and 6/13 in the midperiphery. 4/13 were inferotemporal, 4/13 superiotemporal, 3/13 superionasal and 2/13 inferonasal. Fluorescein angiography showed in 7/13 eyes an occult choroidal neovascularization (OCN), in 9/13 eyes hemorrhages. 3/5 eyes had a peripheral detachment of the retinal pigment epithelium in OCT, in 8 eyes the lesion was too peripheral to perform OCT. 11/13 eyes had also ARMD, all non-exudative. Size of lesions was between 5- 10 disc diameters. 11/13 eyes were treated with laser coagulation. In 10/11 eyes the lesion stabilized after laser treatment. 8/11 eyes had stable BCVA with +/- 1 line, 2/11 eyes gained > 2 lines and 1/11 eyes had BCVA deterioration with loss of > 2 lines after treatment.

Conclusions: : Peripheral hemorrhagic exudative chorioretinopathy is rare and can lead in the advanced stages to permanent loss of vision. Retinal laser coagulation is a good treatment modality to prevent a progression of the lesion to the macula.

Keywords: choroid: neovascularization • retinal neovascularization • age-related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×